Fig. 5From: Leveraging a disulfidptosis‑related lncRNAs signature for predicting the prognosis and immunotherapy of gliomaROC curves and the establishment of a nomogram. (A). The plot showing the AUC values for various risk factors, including risk scores, age, gender, and tumor grade. (B). The AUC of the CRL signature for 1-, 3-, and 5-year survival rates in glioma. (C). The plot showing the concordance index of the risk factors, which includes risk scores, age, gender, and tumor grade. (D). A nomogram predicting the 1-, 3- and 5-year survival rates for glioma using independent prognostic factors (grade, age, and risk score). (E) A calibration curves indicating the concordance between the prediction by the nomogram and actual survival ratesBack to article page